Crestline Management, LP - Q2 2017 holdings

$746 Million is the total value of Crestline Management, LP's 130 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was - .

 Value Shares↓ Weighting
MON NewMONSANTO CO NEW$6,273,00053,000
+100.0%
0.84%
VRSK NewVERISK ANALYTICS INC$5,844,00069,264
+100.0%
0.78%
APD NewAIR PRODS & CHEMS INC$4,649,00032,500
+100.0%
0.62%
DNB NewDUN & BRADSTREET CORP DEL NE$4,613,00042,653
+100.0%
0.62%
AJG NewGALLAGHER ARTHUR J & CO$3,798,00066,345
+100.0%
0.51%
RGA NewREINSURANCE GROUP AMER INC$3,470,00027,029
+100.0%
0.46%
FIS NewFIDELITY NATL INFORMATION SV$3,308,00038,730
+100.0%
0.44%
FDS NewFACTSET RESH SYS INC$3,258,00019,605
+100.0%
0.44%
AMP NewAMERIPRISE FINL INC$2,972,00023,345
+100.0%
0.40%
AMG NewAFFILIATED MANAGERS GROUP$2,662,00016,047
+100.0%
0.36%
V NewVISA INC$2,650,00028,254
+100.0%
0.36%
BIIB NewBIOGEN INC$2,590,0009,543
+100.0%
0.35%
AIZ NewASSURANT INC$2,528,00024,376
+100.0%
0.34%
UBSI NewUNITED BANKSHARES INC WEST V$2,430,00062,000
+100.0%
0.33%
MET NewMETLIFE INC$2,393,00043,555
+100.0%
0.32%
FICO NewFAIR ISAAC CORP$2,307,00016,545
+100.0%
0.31%
AMTD NewTD AMERITRADE HLDG CORP$2,296,00053,407
+100.0%
0.31%
FITB NewFIFTH THIRD BANCORP$2,207,00085,000
+100.0%
0.30%
CFG NewCITIZENS FINL GROUP INC$2,141,00060,000
+100.0%
0.29%
NBIX NewNEUROCRINE BIOSCIENCES INC$2,054,00044,658
+100.0%
0.28%
ATH NewATHENE HLDG LTDcl a$2,019,00040,698
+100.0%
0.27%
TSS NewTOTAL SYS SVCS INC$1,860,00031,930
+100.0%
0.25%
PTCT NewPTC THERAPEUTICS INC$1,792,00097,789
+100.0%
0.24%
PRTK NewPARATEK PHARMACEUTICALS INC$1,730,00071,799
+100.0%
0.23%
HUM NewHUMANA INC$1,735,0007,212
+100.0%
0.23%
WRB NewBERKLEY W R CORP$1,568,00022,663
+100.0%
0.21%
GDI NewGARDNER DENVER HLDGS INC$1,559,00072,147
+100.0%
0.21%
ACGL NewARCH CAP GROUP LTDord$1,511,00016,202
+100.0%
0.20%
AHL NewASPEN INSURANCE HOLDINGS LTD$1,457,00029,221
+100.0%
0.20%
WLTW NewWILLIS TOWERS WATSON PUB LTD$1,443,0009,917
+100.0%
0.19%
NDAQ NewNASDAQ INC$1,429,00019,988
+100.0%
0.19%
NUVA NewNUVASIVE INC$1,386,00018,022
+100.0%
0.19%
SBPH NewSPRING BK PHARMACEUTICALS IN$1,335,00098,581
+100.0%
0.18%
RIGL NewRIGEL PHARMACEUTICALS INC$1,288,000471,693
+100.0%
0.17%
VVV NewVALVOLINE INC$1,216,00051,250
+100.0%
0.16%
TROW NewPRICE T ROWE GROUP INC$1,143,00015,399
+100.0%
0.15%
ICE NewINTERCONTINENTAL EXCHANGE IN$1,137,00017,242
+100.0%
0.15%
NCR NewNCR CORP NEW$1,121,00027,447
+100.0%
0.15%
AZPN NewASPEN TECHNOLOGY INC$1,102,00019,947
+100.0%
0.15%
RDUS NewRADIUS HEALTH INC$1,087,00024,036
+100.0%
0.15%
AFG NewAMERICAN FINL GROUP INC OHIO$1,093,00010,997
+100.0%
0.15%
PRI NewPRIMERICA INC$1,092,00014,420
+100.0%
0.15%
LPLA NewLPL FINL HLDGS INC$1,075,00025,319
+100.0%
0.14%
SSD NewSIMPSON MANUFACTURING CO INC$1,075,00024,586
+100.0%
0.14%
BXS NewBANCORPSOUTH INC$1,068,00035,000
+100.0%
0.14%
ZGNX NewZOGENIX INC$1,045,00072,091
+100.0%
0.14%
BLUE NewBLUEBIRD BIO INC$1,036,0009,859
+100.0%
0.14%
PTLA NewPORTOLA PHARMACEUTICALS INC$1,028,00018,305
+100.0%
0.14%
RXDX NewIGNYTA INC$958,00092,561
+100.0%
0.13%
AERI NewAERIE PHARMACEUTICALS INC$947,00018,024
+100.0%
0.13%
NewOM ASSET MGMT PLC$885,00059,533
+100.0%
0.12%
ALNY NewALNYLAM PHARMACEUTICALS INC$863,00010,814
+100.0%
0.12%
SEIC NewSEI INVESTMENTS CO$778,00014,464
+100.0%
0.10%
STML NewSTEMLINE THERAPEUTICS INC$774,00084,106
+100.0%
0.10%
SNDX NewSYNDAX PHARMACEUTICALS INC$773,00055,368
+100.0%
0.10%
BLBD NewBLUE BIRD CORP$775,00045,569
+100.0%
0.10%
IMGN NewIMMUNOGEN INC$771,000108,435
+100.0%
0.10%
CNO NewCNO FINL GROUP INC$713,00034,151
+100.0%
0.10%
RDN NewRADIAN GROUP INC$694,00042,416
+100.0%
0.09%
MCO NewMOODYS CORP$661,0005,434
+100.0%
0.09%
HCA NewHCA HEALTHCARE INC$629,0007,209
+100.0%
0.08%
LPX NewLOUISIANA PAC CORP$593,00024,607
+100.0%
0.08%
MS NewMORGAN STANLEY$561,00012,579
+100.0%
0.08%
HRTX NewHERON THERAPEUTICS INC$513,00037,020
+100.0%
0.07%
AKBA NewAKEBIA THERAPEUTICS INC$504,00035,098
+100.0%
0.07%
EMN NewEASTMAN CHEM COcall$454,0001,500
+100.0%
0.06%
IESC NewIES HLDGS INC$437,00024,077
+100.0%
0.06%
GNMK NewGENMARK DIAGNOSTICS INC$426,00036,046
+100.0%
0.06%
FRTA NewFORTERRA INC$348,00042,330
+100.0%
0.05%
ADM NewARCHER DANIELS MIDLAND COput$345,0002,000
+100.0%
0.05%
AXGT NewAXOVANT SCIENCES LTD$334,00014,419
+100.0%
0.04%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$318,00043,254
+100.0%
0.04%
BKFS NewBLACK KNIGHT FINL SVCS INCcl a$302,0007,376
+100.0%
0.04%
CE NewCELANESE CORP DELcall$280,0001,000
+100.0%
0.04%
BRO NewBROWN & BROWN INC$273,0006,332
+100.0%
0.04%
DBVT NewDBV TECHNOLOGIES S Asponsored adr$257,0007,210
+100.0%
0.03%
VSAR NewVERSARTIS INC$252,00014,418
+100.0%
0.03%
GE NewGENERAL ELECTRIC COput$210,0002,500
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DENALI THERAPEUTICS INC24Q3 202398.0%
MICROCHIP TECHNOLOGY INC.20Q3 20231.0%
META PLATFORMS INC16Q3 20233.8%
ANALOG DEVICES INC16Q3 20231.8%
VOYA FINL INC15Q2 20231.3%
AMERICAN INTL GROUP INC14Q3 20231.6%
MICROSOFT CORP14Q3 20232.0%
GRAPHIC PACKAGING HLDG CO14Q3 20230.9%
JUNO THERAPEUTICS INC13Q4 2017100.0%
ALLSTATE CORP13Q3 20231.9%

View Crestline Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-12
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
42022-06-16
13F-HR2022-05-16

View Crestline Management, LP's complete filings history.

Compare quarters

Export Crestline Management, LP's holdings